These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 3275584)

  • 1. Enterotoxigenic Escherichia coli diarrhea in an endemic area prepares the intestine for an anamnestic immunoglobulin A antitoxin response to oral cholera B subunit vaccination.
    Holmgren J; Svennerholm AM; Gothefors L; Jertborn M; Stoll B
    Infect Immun; 1988 Jan; 56(1):230-3. PubMed ID: 3275584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cross-protection by B subunit-whole cell cholera vaccine against diarrhea associated with heat-labile toxin-producing enterotoxigenic Escherichia coli: results of a large-scale field trial.
    Clemens JD; Sack DA; Harris JR; Chakraborty J; Neogy PK; Stanton B; Huda N; Khan MU; Kay BA; Khan MR
    J Infect Dis; 1988 Aug; 158(2):372-7. PubMed ID: 3042876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A tripartite fusion, FaeG-FedF-LT(192)A2:B, of enterotoxigenic Escherichia coli (ETEC) elicits antibodies that neutralize cholera toxin, inhibit adherence of K88 (F4) and F18 fimbriae, and protect pigs against K88ac/heat-labile toxin infection.
    Ruan X; Liu M; Casey TA; Zhang W
    Clin Vaccine Immunol; 2011 Oct; 18(10):1593-9. PubMed ID: 21813665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and preclinical evaluation of safety and immunogenicity of an oral ETEC vaccine containing inactivated E. coli bacteria overexpressing colonization factors CFA/I, CS3, CS5 and CS6 combined with a hybrid LT/CT B subunit antigen, administered alone and together with dmLT adjuvant.
    Holmgren J; Bourgeois L; Carlin N; Clements J; Gustafsson B; Lundgren A; Nygren E; Tobias J; Walker R; Svennerholm AM
    Vaccine; 2013 May; 31(20):2457-64. PubMed ID: 23541621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Saliva, breast milk, and serum antibody responses as indirect measures of intestinal immunity after oral cholera vaccination or natural disease.
    Jertborn M; Svennerholm AM; Holmgren J
    J Clin Microbiol; 1986 Aug; 24(2):203-9. PubMed ID: 3528211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attenuated Escherichia coli strains expressing the colonization factor antigen I (CFA/I) and a detoxified heat-labile enterotoxin (LThK63) enhance clearance of ETEC from the lungs of mice and protect mice from intestinal ETEC colonization and LT-induced fluid accumulation.
    Byrd W; Boedeker EC
    Vet Immunol Immunopathol; 2013 Mar; 152(1-2):57-67. PubMed ID: 23122616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antigen-specific memory B-cell responses to enterotoxigenic Escherichia coli infection in Bangladeshi adults.
    Alam MM; Aktar A; Afrin S; Rahman MA; Aktar S; Uddin T; Rahman MA; Al Mahbuba D; Chowdhury F; Khan AI; Bhuiyan TR; Begum YA; Ryan ET; Calderwood SB; Svennerholm AM; Qadri F
    PLoS Negl Trop Dis; 2014 Apr; 8(4):e2822. PubMed ID: 24762744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intestinal antibody response after oral immunization with a prototype cholera B subunit-colonization factor antigen enterotoxigenic Escherichia coli vaccine.
    Ahrén C; Wennerås C; Holmgren J; Svennerholm AM
    Vaccine; 1993; 11(9):929-34. PubMed ID: 8212839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Secretory IgA-mediated protection against V. cholerae and heat-labile enterotoxin-producing enterotoxigenic Escherichia coli by rice-based vaccine.
    Tokuhara D; Yuki Y; Nochi T; Kodama T; Mejima M; Kurokawa S; Takahashi Y; Nanno M; Nakanishi U; Takaiwa F; Honda T; Kiyono H
    Proc Natl Acad Sci U S A; 2010 May; 107(19):8794-9. PubMed ID: 20421480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in cross-protection in rats immunized with the B subunits of cholera toxin and Escherichia coli heat-labile toxin.
    Klipstein FA; Engert RF; Clements JD; Houghten RA
    Infect Immun; 1984 Mar; 43(3):811-6. PubMed ID: 6365784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Construction and preclinical evaluation of recombinant Peru-15 expressing high levels of the cholera toxin B subunit as a vaccine against enterotoxigenic Escherichia coli.
    Roland KL; Cloninger C; Kochi SK; Thomas LJ; Tinge SA; Rouskey C; Killeen KP
    Vaccine; 2007 Dec; 25(51):8574-84. PubMed ID: 18045752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcutaneous immunization with the heat-labile toxin (LT) of enterotoxigenic Escherichia coli (ETEC): protective efficacy in a double-blind, placebo-controlled challenge study.
    McKenzie R; Bourgeois AL; Frech SA; Flyer DC; Bloom A; Kazempour K; Glenn GM
    Vaccine; 2007 May; 25(18):3684-91. PubMed ID: 17313998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluating the A-Subunit of the Heat-Labile Toxin (LT) As an Immunogen and a Protective Antigen Against Enterotoxigenic Escherichia coli (ETEC).
    Norton EB; Branco LM; Clements JD
    PLoS One; 2015; 10(8):e0136302. PubMed ID: 26305793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibodies derived from a toxoid MEFA (multiepitope fusion antigen) show neutralizing activities against heat-labile toxin (LT), heat-stable toxins (STa, STb), and Shiga toxin 2e (Stx2e) of porcine enterotoxigenic Escherichia coli (ETEC).
    Rausch D; Ruan X; Nandre R; Duan Q; Hashish E; Casey TA; Zhang W
    Vet Microbiol; 2017 Apr; 202():79-89. PubMed ID: 26878972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protection of piglets against enteric colibacillosis by intranasal immunization with K88ac (F4ac) fimbriae and heat labile enterotoxin of Escherichia coli.
    Lin J; Mateo KS; Zhao M; Erickson AK; Garcia N; He D; Moxley RA; Francis DH
    Vet Microbiol; 2013 Mar; 162(2-4):731-739. PubMed ID: 23089483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcutaneous immunization using colonization factor and heat-labile enterotoxin induces correlates of protective immunity for enterotoxigenic Escherichia coli.
    Yu J; Cassels F; Scharton-Kersten T; Hammond SA; Hartman A; Angov E; Corthésy B; Alving C; Glenn G
    Infect Immun; 2002 Mar; 70(3):1056-68. PubMed ID: 11854183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of efficacy of CVD 103-HgR live oral cholera vaccine against all-cause travellers' diarrhoea in a randomised, double-blind, placebo-controlled study.
    Leyten EM; Soonawala D; Schultsz C; Herzog C; Ligthelm RJ; Wijnands S; Visser LG
    Vaccine; 2005 Oct; 23(43):5120-6. PubMed ID: 15982790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-replicating oral whole cell vaccine protective against enterotoxigenic Escherichia coli (ETEC) diarrhea: stimulation of anti-CFA (CFA/I) and anti-enterotoxin (anti-LT) intestinal IgA and protection against challenge with ETEC belonging to heterologous serotypes.
    Evans DG; Evans DJ; Opekun AR; Graham DY
    FEMS Microbiol Immunol; 1988 Dec; 1(3):117-25. PubMed ID: 3078739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Local and systemic antibody responses to naturally acquired enterotoxigenic Escherichia coli diarrhea in an endemic area.
    Stoll BJ; Svennerholm AM; Gothefors L; Barua D; Huda S; Holmgren J
    J Infect Dis; 1986 Mar; 153(3):527-34. PubMed ID: 3512729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preexisting antibodies to homologous colonization factors and heat-labile toxin in serum, and the risk to develop enterotoxigenic Escherichia coli-associated diarrhea.
    Tobias J; Andersson K; Bialik A; Cohen D
    Diagn Microbiol Infect Dis; 2008 Feb; 60(2):229-31. PubMed ID: 17964106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.